aboutnav prodnav sciandpubnav newsnavroll investorsnavroll careersnav contactnav

Cornerstone Therapeutics Announces New Board of Directors

Critical Therapeutics, Inc. Announces Stockholder Approvals Related to Merger with Cornerstone BioPharma Holdings, Inc. and 10-to-1 Reverse Stock Split

 
 

 


FORWARD-LOOKING STATEMENTS, click here.

Home | About | Products | Development Pipeline | News | Investors | Careers

For Terms of Use and Disclaimer, click here. For Privacy Policy, click here.
This site is intended for residents of the United States, Puerto Rico and U.S. territories.


© 2008 Cornerstone Therapeutics Inc., Cary, NC. All rights reserved.
Unless otherwise specified, all product names in this Internet site are trademarks owned by or licensed to Cornerstone Therapeutics Inc., its subsidiaries or affiliates. Use of any Cornerstone Therapeutics trademark, trade name or trade dress in this site without the prior written authorization of Cornerstone Therapeutics Inc., except to identify the product of the company, is strictly prohibited.